|
|
Article: HHS/FDA GRANTS TENTATIVE APPROVAL FOR 75TH GENERIC ANTI-RETROVIRAL DRUG AS PART OF PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF
- Article from:
- US Fed News Service, Including US State News
- Article date:
- October 29, 2008
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
The U.S. Department of Health & Human Services' Food & Drug Administration issued the following press release:
The Food and Drug Administration within the U.S. Department of Health and Human Services (HHS) has reached the milestone of the 75th anti-retroviral generic drug approved or tentatively approved as part of President Bush's Emergency Plan for AIDS Relief (PEPFAR).
Marketed by Macleods Pharmaceuticals, Ltd, of Kachigam, Daman, in the Republic of India, the 75th drug is 150 milligram and 300 milligram tablets of generic lamivudine, a nucleoside analog reverse-transcriptase inhibitor (nRTI), which blocks an enzyme called reverse transcriptase, important to HIV production. ...